Abstract:Pseudomonas aeruginosa, a formidable pathogen renowned for its antimicrobial resistance, poses a significant threat to immunocompromised individuals. In that respect, the MexAB-OprM efflux pump plays a pivotal line of defense by extruding antimicrobials from bacterial cells. The inner membrane homotrimeric protein, MexB, captures antibiotics and translocate them into the outer membrane OprM channel protein connected through the MexA adaptor protein. Despite extensive efforts, competitive inhibitors targeting the tight (T) protomer of the MexB protein have not received FDA approval for medical use. Over the past few years, allosteric inhibitors have become popular as an alternative to the classical competitive inhibitor-based approach because of higher specificity, lower dosage, and reduced toxicological effects. Hence, in this study, we unveiled the existence of a transmembrane allosteric binding pocket of MexB inspired by the recent discovery of an important allosteric inhibitor, BDM88855, for homologs AcrB protein. While repurposing BDM88855 proved ineffective for controlling the MexB loose (L) protomer, our investigation identified a promising alternative— a chlorine-containing variant of DB08385 (2-Cl DB08385 or Variant 1). Molecular dynamics simulations, including binding free energy estimation coupled with heterogeneous dielectric implicit membrane model (implicit-membrane MM/PBSA), interaction entropy (IE) analysis and the potential of mean force (PMF) calculation demonstrated Variant 1's superior binding affinity to the transmembrane pocket, displaying the highest energy barrier in the ligand unbinding process. To elucidate the allosteric crosstalk between the transmembrane and porter domain of MexB, we employed the 'Eigenvector Centrality' measure in the linear mutual information obtained from the protein correlation network. Notably, this study confirmed the presence of an allosteric transmembrane site in MexB L protomer. In addition to that, Variant 1 emerged as a potent regulator of allosteric crosstalk, inducing an 'O – L intermediate state' in MexB L protomer. This induced state might hold the potential to diminish substrate intake into the access pocket leading to ineffective efflux of the antibiotics.

Machine Learning-Guided Discovery of AcrB and MexB Efflux Pump Inhibitors

Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from Escherichia coli

Evaluation and Target Validation of Indole Derivatives As Inhibitors of the AcrAB-TolC Efflux Pump.

In-silico interaction studies suggest RND efflux pump mediates polymyxin resistance in Acinetobacter baumannii

Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria

RND-type Drug Eﬄux Pumps from Gram-negative Bacteria: Molecular Mechanism and Inhibition

Required criteria of drug efflux pump inhibitors to disrupt the function of AcrB subunit protein from AcrAB-TolC multidrug efflux pump from Escherichia coli

Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps

Mechanistic Duality of Bacterial Efflux Substrates and Inhibitors: Example of Simple Substituted Cinnamoyl and Naphthyl Amides

RND Efflux Pump Induction: A Crucial Network Unveiling Adaptive Antibiotic Resistance Mechanisms of Gram-Negative Bacteria

Evaluation of a Series of 2-Napthamide Derivatives As Inhibitors of the Drug Efflux Pump AcrB for the Reversal of Antimicrobial Resistance

Efflux-mediated Multidrug Resistance in Critical Gram-negative Bacteria and Natural Efflux Pump Inhibitors

Structures and Efflux Mechanisms of the AcrAB-TolC Pump

Types and Mechanisms of Efflux Pump Systems and the Potential of Efflux Pump Inhibitors in the Restoration of Antimicrobial Susceptibility, with a Special Reference to Acinetobacter baumannii

Perturbed structural dynamics underlie inhibition and altered efflux of the multidrug resistance pump AcrB

Kinetic Analysis of the Inhibition of the Drug Efflux Protein AcrB Using Surface Plasmon Resonance.

Deciphering the molecular and functional basis of TMexCD1: the plasmid-encoded efflux pump of resistance-nodulation-division superfamily

Different Efflux Pump Systems in Acinetobacter baumannii and Their Role in Multidrug Resistance

Multidrug Efflux Systems Involved in Resistance to Antibacterial Drugs

Mechanism of drug resistance in bacteria: efflux pump modulation for designing of new antibiotic enhancers

Exploring the Transmembrane Allostery in MexB: DB08385 Variant as Promising Inhibitor like Candidate Against Pseudomonas aeruginosa Antibiotic Resistance – A Computational Study